BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil. Mazzonetto P, Milanezi F, D'Andrea M, Martins S, et al. Breast Cancer Res Treat 2023 Mar 7. doi: 10.1007/s10549-023-06892.

Read + Share

Amedeo Smart

Independent Medical Education

Mazzonetto P, Milanezi F, D'Andrea M, Martins S, et al. BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil. Breast Cancer Res Treat 2023 Mar 7. doi: 10.1007/s10549-023-06892.
PMID: 36881271